NRX Pharmaceuticals, Inc. (NRXP)
Nasdaq: NRXP · Pharmaceutical Preparations · Wilmington, DE · filing with the SEC since 2017
Filings
395 filings since 2017 beside 84 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 48 days after the quarter ended. The proxy statement was last filed Nov 5, 2026.
Filings a yearinsider forms included
21321189245504633
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 9 times in the last 36 months, the newest Mar 24, 2026.Listing warning from its exchange (8-K item 3.01): 4 times in the last 36 months, the newest Jan 16, 2026.Auditor change (8-K item 4.01): 3 times in the last 36 months, the newest Nov 26, 2025.Debt trigger or default notice (8-K item 2.04): 1 time in the last 36 months, the newest Apr 30, 2024.SEC letters: 2 in the last 36 months, the newest Dec 18, 2025.A late-filing notice, Form NT 10-Q, filed Aug 14, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Jun 4, 2026
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Jun 3, 2026
Mar 24, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
Mar 23, 2026
Jan 16, 2026
8-K items 3.01, 7.01, 8.01, 9.01
Listing warning from its exchange; Investor disclosure (Regulation FD); Other event · Current report
Jan 12, 2026
Nov 21, 2025
8-K/A item 9.01
Financial statements and exhibits · Current report, amended
Sep 8, 2025
Oct 23, 2025
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Oct 17, 2025
Sep 12, 2025
8-K items 2.01, 7.01, 9.01
Purchase or sale of a business completed; Investor disclosure (Regulation FD) · Current report
Sep 8, 2025
40 of 395 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.